Vaccination News Home Page

http://journals.bmn.com/journals/list/latest?uid=JIMM.etd01438_09527915_v0014i05_00000385&rendertype=abstract&node=TOC%40%40JIMM%4014%4005%4014_05

 
Research
Tools
Reviews Journal
Collection
News &
Comment
Books &
Labware
Science
Jobs
Web
Links
journals.bmn.com Latest
Updates
A-Z list Trends
Guides
My E-mail
Alerts
MEDLINE Section
Search
  My BMN My BMN Exit Exit  
  Send Feedback to BMN Feedback Help System Help  


 

Current Opinion in Immunology
 Latest Issue
 Browse Issues
 Browse by Topic
 Search this Journal
 Prices & Subscriptions
 About this Journal
 Publishers Site


 

Quick Site Search

 

Advanced site search


 

   Jump to :

 
  
   Vol
  Page
    
   Fill in Vol and Page   


 

 


 
Current Opinion in Immunology

Full A-Z Journal ListVol. 14, No. 5, October 2002Abstract

 
 
Novel vaccines protecting against the development of allergic disorders: a double-edged sword? [Review]
Klaus J. Erb and Gisela Wohlleben
Current Opinion in Immunology, 2002, 14:5:633-643


Abstract


 

The severity and incidence of allergic disorders is steadily increasing despite the widespread use of steroids and other drugs. Recent results obtained in animals suggest that it may be possible to develop novel anti-allergy vaccines for human use, thereby stopping this alarming worldwide increase in allergic diseases. The most promising approaches are the induction of allergen-specific T helper 1 or allergen-specific T regulatory responses. However, both approaches potentially harbour negative side effects that need to be ruled out before vaccinating young children — the best candidates for the primary prevention of allergic disorders. (Like maybe the possibility that vaccines are at least partly responsible for this alarming rise in allergies? - SM)



 

 Full Text Access
  

Purchase Options

 
 Buy this Single Article     $ 15.00
    

Subscriber Access

 
 Personal Subscription Access
 Institutional Subscription Access


 
Sorry. Your institute does not have full text access rights to articles from this journal.
Full text access to all Trends and Current Opinion titles is now available in BioMedNet Reviews.


If you previously had full text access, your institute may have been on a trial or had a subscription which has now ended.
Please contact your librarian about an institutional subscription to BioMedNet Reviews.
 
Security Information

 
  All BioMedNet purchases are fully secure.

 


BioMedNet
Home
Journal
Collection
My BMN
 
Help System
 
Send Feedback to BMN
 
Information for Advertisers © Elsevier Science Limited 2002

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.